| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cadrenal Therapeutics, Inc. (CVKD) has 3 insiders with recent SEC Form 4 filings, including 11 buys and 6 sells. CVKD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 196.1K | $1.19M | - | |
| Dir | 5.0K | $30.4K | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2025 | Pham Quang X49 | CEO And Chairman | Sell | 9,371 | $14.06 | $131,779.29 | -2.2% | -48.1% | - | |
| Aug 28, 2025 | Szot Matthew K45 | Chief Financial Officer | Sell | 2,000 | $14.00 | $27,992.00 | -3.1% | -29.4% | - | |
| Aug 28, 2025 | Pham Quang X49 | CEO And Chairman | Sell | 5,029 | $13.99 | $70,355.71 | -1.2% | -29.4% | - | |
| Oct 5, 2023 | Murphy John Raymond48 | Director | Buy | 20,000 | $0.70 | $13,973.31 | +1.7% | -2.9% | +22.1% | |
| Sep 5, 2023 | Pham Quang X49 | CEO And Chairman | Buy | 40,000 | $0.90 | $36,188.00 | +0.6% | -42.5% | -37.9% | |
| Sep 1, 2023 | Pham Quang X49 | CEO And Chairman | Buy | 70,000 | $0.91 | $63,945.00 | +0.4% | -48.4% | -43.0% | |
| Mar 21, 2023 | Murphy John Raymond48 | Director | Buy | 10,000 | $1.39 | $13,900.00 | +1.7% | +26.4% | -52.0% | |
| Mar 16, 2023 | Murphy John Raymond48 | Director | Buy | 20,000 | $1.67 | $33,398.00 | +3.6% | +7.2% | -60.6% |